Search
Search
About
Log in
Join
Experiences with
Immunotherapy
Posts
Communities
1,691 public posts
Filter results
Intersitial Lung Disease and Lung Cancer
We have been told he cannot have radiotherapy or
immunotherapy
because of intersitial lung disease and was wondering if anyone on these threads had any further information on treatments for ILD and Lung Cancer. So far I am not having any luck in finding any alternative treatments.
We have been told he cannot have radiotherapy or
immunotherapy
because of intersitial lung disease and was wondering if anyone on these threads had any further information on treatments for ILD and Lung Cancer. So far I am not having any luck in finding any alternative treatments.
Clairebrocks
in
The Roy Castle Lung Cancer Foundation
5 months ago
FDA clearance for SYNC-T SV-102, a pioneering combo immunotherapy for Metastatic Castrate-Resistant Prostate Cancer
Source link: https://finance.yahoo.com/news/syncromune-inc-announces-fda-clearance-232200345.html SYNC-T SV-102 Therapy combines partial tumor oncolysis with a fixed-dose combination multi-target biologic drug to provide a novel, personalized therapeutic approach for the treatment of metastatic
Source link: https://finance.yahoo.com/news/syncromune-inc-announces-fda-clearance-232200345.html SYNC-T SV-102 Therapy combines partial tumor oncolysis with a fixed-dose combination multi-target biologic drug to provide a novel, personalized therapeutic approach for the treatment of metastatic
God_Loves_Me
in
Advanced Prostate Cancer
2 months ago
clinical trial still recruiting: JNJ-78278343 immunotherapy targeting KLK2-CD3
https://classic.clinicaltrials.gov/ct2/show/NCT06095089 Conceptually promising but still phase 1/2
https://classic.clinicaltrials.gov/ct2/show/NCT06095089 Conceptually promising but still phase 1/2
Maxone73
in
Advanced Prostate Cancer
5 months ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
For people considering immunotherapy: AI algorithms reveal a bone metastasis-related signature of circulating tumor cells in PCa
Certain genetic profiles respond better to immune therapy than others... https://www.nature.com/articles/s41597-024-03551-2
Certain genetic profiles respond better to immune therapy than others... https://www.nature.com/articles/s41597-024-03551-2
Maxone73
in
Advanced Prostate Cancer
20 days ago
Activating lipid nanoparticles can streamline the production of CAR T-cells for cancer immunotherapy
A bio- engineering breakthrough is reported here https://phys.org/news/2024-03-method-car-cells-lipid-nanoparticles.html and the article includes a link to the open access research paper. Sorry, that's all folks. This is a phone and I'm on holiday. Italy shouldn't be this wet. Ciao.
A bio- engineering breakthrough is reported here https://phys.org/news/2024-03-method-car-cells-lipid-nanoparticles.html and the article includes a link to the open access research paper. Sorry, that's all folks. This is a phone and I'm on holiday. Italy shouldn't be this wet. Ciao.
bennevisplace
in
CLL Support
4 months ago
Some news about immunotherapy
https://www.mdpi.com/2072-6694/13/9/2187
https://www.mdpi.com/2072-6694/13/9/2187
Maxone73
in
Advanced Prostate Cancer
8 months ago
Companies that test liver biospy tissue to see what immunotherapy, parp inhibitors or ATK inhibitors would work?
as above, so far pca Adenocarcinoma in liver biopsy tissue…. Anyone have a list?
as above, so far pca Adenocarcinoma in liver biopsy tissue…. Anyone have a list?
Shorehousejam
in
Advanced Prostate Cancer
2 months ago
Assessing the Benefit of CAR T-cell Therapies for mCRPC
Research conducted by City of Hope, as well as support from the Prostate Cancer Foundation, revealed minimal adverse effects from the
immunotherapy
, and promising activity.
Research conducted by City of Hope, as well as support from the Prostate Cancer Foundation, revealed minimal adverse effects from the
immunotherapy
, and promising activity.
God_Loves_Me
in
Advanced Prostate Cancer
14 days ago
Some Reference Material - NECP/SCCP
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer, 2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290806/
Immunotherapy
for Prostate Cancer: A Current Systematic Review and Patient Centric Perspectives, 2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966657
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer, 2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290806/
Immunotherapy
for Prostate Cancer: A Current Systematic Review and Patient Centric Perspectives, 2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966657
skiingfiend
in
Advanced Prostate Cancer
5 months ago
Is there an "oligometastatic state" for prostate cancer (but not in breast cancer or lung cancer)?
All were given systemic therapy (90% had both
immunotherapy
+ chemotherapy). 81 were treated with "consolidative therapy" radiation/surgery to the lung and all metastatic sites followed by systemic therapy. After 2 years of follow-up: • Overall survival was the same in both groups.
All were given systemic therapy (90% had both
immunotherapy
+ chemotherapy). 81 were treated with "consolidative therapy" radiation/surgery to the lung and all metastatic sites followed by systemic therapy. After 2 years of follow-up: • Overall survival was the same in both groups.
Tall_Allen
in
Advanced Prostate Cancer
2 months ago
AMG 509 (Xaluritamig): update on this immunotherapy for mCRPC
They published the first findings on Cancer Discovery. "Efficacy as measured both by PSA and objective response by RECIST were encouraging in this heavily pretreated mCRPC population, and responses occurred with greater frequency in the higher-dose cohorts. PSA declines were seen starting with 0.1 mg
They published the first findings on Cancer Discovery. "Efficacy as measured both by PSA and objective response by RECIST were encouraging in this heavily pretreated mCRPC population, and responses occurred with greater frequency in the higher-dose cohorts. PSA declines were seen starting with 0.1 mg
Maxone73
in
Advanced Prostate Cancer
6 months ago
Advances in solid tumors: finnish clinical trial
Bexmarilimab seems to be able to improve
immunotherapy
. It was not yet tested on prostate cancer, but it's already commercially used to treat blood malignacies.
Bexmarilimab seems to be able to improve
immunotherapy
. It was not yet tested on prostate cancer, but it's already commercially used to treat blood malignacies.
Maxone73
in
Advanced Prostate Cancer
7 months ago
BAT & Nivolumab
It is a type of
immunotherapy
and works as a checkpoint inhibitor, blocking a signal that prevents activation of T cells from attacking the cancer." [2] "The primary endpoint of a confirmed PSA50 response rate was met and estimated at 40% (N = 18/45 ... against the 25% null hypothesis).
It is a type of
immunotherapy
and works as a checkpoint inhibitor, blocking a signal that prevents activation of T cells from attacking the cancer." [2] "The primary endpoint of a confirmed PSA50 response rate was met and estimated at 40% (N = 18/45 ... against the 25% null hypothesis).
pca2004
in
Fight Prostate Cancer
7 months ago
Immunotherapy.
It wasn't me but my husband.he started this journey 21 months ago.He was on keytruda every 3 weeks from Feb 22 until May 23. ..the side effects for him was varied but breathless and skin problems....in May this year he had left upper lobe removed ...and to date he is nearly finishes 25 radiotherapy
It wasn't me but my husband.he started this journey 21 months ago.He was on keytruda every 3 weeks from Feb 22 until May 23. ..the side effects for him was varied but breathless and skin problems....in May this year he had left upper lobe removed ...and to date he is nearly finishes 25 radiotherapy
Ceibach
in
The Roy Castle Lung Cancer Foundation
11 months ago
FDA Clearance of FK-PC101, a Novel Personalized Prostate Cancer Immunotherapy
not for stage 4 fighters...but still... "The trial, CELLVX-230, is a randomized, multicenter, open-label study of irradiated autologous cellular vaccine in men with high-risk prostate cancer post-radical prostatectomy. It will be conducted through a partnership with the Society of Urologic Oncology
not for stage 4 fighters...but still... "The trial, CELLVX-230, is a randomized, multicenter, open-label study of irradiated autologous cellular vaccine in men with high-risk prostate cancer post-radical prostatectomy. It will be conducted through a partnership with the Society of Urologic Oncology
Maxone73
in
Advanced Prostate Cancer
6 months ago
Immunotherapy and Cryotherapy
Has anyone had good results with
Immunotherapy
with Cryotherapy? Thank you
Has anyone had good results with
Immunotherapy
with Cryotherapy? Thank you
spolyu
in
Advanced Prostate Cancer
10 months ago
Plant Virus Fights Breast Cancer (similar to Prostate Cancer) in Mice With 'Widespread Effectiveness
The virus doesn't directly attack cancer cells in mice, but acts as a form of
immunotherapy
– a treatment that helps the body's own immune system find and destroy cancer.
The virus doesn't directly attack cancer cells in mice, but acts as a form of
immunotherapy
– a treatment that helps the body's own immune system find and destroy cancer.
cesanon
in
Advanced Prostate Cancer
2 months ago
A new immunotherapy trial?
Not really super new...but maybe it could help someone! https://jitc.bmj.com/content/10/Suppl_2/A781 For advanced prostate cancer and other solid tumors
Not really super new...but maybe it could help someone! https://jitc.bmj.com/content/10/Suppl_2/A781 For advanced prostate cancer and other solid tumors
Maxone73
in
Advanced Prostate Cancer
9 months ago
immunotherapy
hi there Very low. My midway scans are showing my lymph nodes that grew after my huge debulking surgery in March have not shrunk with the chemotherapy and I have some nodules on peritoneum ( nothing in any organs) So he can’t say that the chemo hasn’t worked in other type cancer but it’s not doing
hi there Very low. My midway scans are showing my lymph nodes that grew after my huge debulking surgery in March have not shrunk with the chemotherapy and I have some nodules on peritoneum ( nothing in any organs) So he can’t say that the chemo hasn’t worked in other type cancer but it’s not doing
Le-gra143
in
My Ovacome
11 months ago
For Neuroendocrine, Small Cell or Mixed PCa/NEPC Cancer, How to Find Out which Immunotherapy is the best to use
MO wants to use Keytruda but it failed in trials isn’t Dostarlimab or atezolizumab better?
MO wants to use Keytruda but it failed in trials isn’t Dostarlimab or atezolizumab better?
Shorehousejam
in
Advanced Prostate Cancer
2 months ago
1
...
4
5
6
...
85
Next page
10
20
30
40
50
60
70
80
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
477 results
The Roy Castle Lung Cancer Foundation
244 results
CLL Support
142 results
View top 10 communities
Sort by
Most Relevant
Newest